Marion L. Hartley

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies

John F. Deeken, Hongkun Wang, Marion L. Hartley et al. · Cancer Chemotherapy and Pharmacology · 2018 · 89 citations

Thrombosis, Medicine, Vascular Malformation +5

Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer

Mohamed E. Salem, Alberto Puccini, Sally J. Trufan et al. · The Oncologist · 2021 · 45 citations · Full text

Neoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future Direction.

Mohamed E. Salem, Marion L. Hartley, Keith Unger et al. · PubMed · 2016 · 30 citations

Surgical Oncology, Adjuvant Chemotherapy, Surgery +17

Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment

Kyung Rae Kim, Reena Jha, Petra Prins et al. · Cancer Chemotherapy and Pharmacology · 2017 · 24 citations

Hepatology, Medicine, Pathology +5

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

Michael J. Pishvaian, Rebecca Slack, Eunice Y. Koh et al. · Cancer Chemotherapy and Pharmacology · 2012 · 17 citations

Medicine, Pathology, Immune Checkpoint Inhibitor +5